Last reviewed · How we verify

NCT03740620

The Effect of Bevel Direction on the Pathway of the Nasotracheal Tube

Completed NA Last updated 4 October 2021
What this trial tests

NA trial testing Bevel facing the cephalad direction of the patient in Epistaxis in 68 participants. Completed in 31 March 2020.

Timeline
14 January 2019
Primary endpoint
31 March 2020
31 March 2020

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment68
Start date14 January 2019
Primary completion31 March 2020
Estimated completion31 March 2020
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

18 and older, any sex, with Epistaxis or Intubation Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the subjects are divided into two groups (group I: intervention group = the nasotracheal tube inserted with the bevel of the nasal tube facing the direction of the patient's head, and Group II: conventional group = the bevel of the tube toward the left side of the subject). After the endotracheal tube is introduced, a flexible endoscope is used to evaluate whether the tube is located below the inferior turbinate, i.e. in the lower pathway.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of bevel direction on the tracheal tube pathway during nasotracheal intubation: A randomised trial.
    Won D, Kim H, Chang JE, Lee JM, et al · · 2021 · cited 8× · PMID 33009189 · DOI 10.1097/eja.0000000000001347

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03740620.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing